These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 34599587

  • 21. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
    Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
    [Abstract] [Full Text] [Related]

  • 22. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
    Bretones P, Riche B, Pichot E, David M, Roy P, Tardy V, Kassai B, Gaillard S, Bernoux D, Morel Y, Chatelain P, Nicolino M, Cornu C, French Collaborative CAH Growth Study Group.
    J Pediatr Endocrinol Metab; 2016 Dec 01; 29(12):1379-1388. PubMed ID: 27852974
    [Abstract] [Full Text] [Related]

  • 23. Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia.
    Liu SC, Suresh M, Jaber M, Mercado Munoz Y, Sarafoglou K.
    Front Endocrinol (Lausanne); 2023 Dec 01; 14():1101843. PubMed ID: 36936152
    [Abstract] [Full Text] [Related]

  • 24. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia.
    Cetinkaya S, Kara C.
    J Pediatr Endocrinol Metab; 2011 Dec 01; 24(5-6):265-9. PubMed ID: 21823521
    [Abstract] [Full Text] [Related]

  • 25. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
    Hoepffner W, Kaufhold A, Willgerodt H, Keller E.
    Horm Res; 2008 Dec 01; 70(1):42-50. PubMed ID: 18493149
    [Abstract] [Full Text] [Related]

  • 26. The validity of the Bayley-Pinneau method in predicting final adult height at the onset of puberty in patients with classic congenital adrenal hyperplasia.
    Badawi N, Fawaz L, Amin A, Kamel A, Arafa N.
    Endokrynol Pol; 2021 Dec 01; 72(4):301-307. PubMed ID: 34010438
    [Abstract] [Full Text] [Related]

  • 27. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia.
    Lin-Su K, Vogiatzi MG, Marshall I, Harbison MD, Macapagal MC, Betensky B, Tansil S, New MI.
    J Clin Endocrinol Metab; 2005 Jun 01; 90(6):3318-25. PubMed ID: 15797962
    [Abstract] [Full Text] [Related]

  • 28. Growth and development in children with classic congenital adrenal hyperplasia.
    Bonfig W.
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb 01; 24(1):39-42. PubMed ID: 27898585
    [Abstract] [Full Text] [Related]

  • 29. Interrelationship of extent of precocious adrenarche in appropriate for gestational age girls with clinical outcome.
    Oron T, Lebenthal Y, de Vries L, Yackobovitch-Gavan M, Phillip M, Lazar L.
    J Pediatr; 2012 Feb 01; 160(2):308-13. PubMed ID: 21907353
    [Abstract] [Full Text] [Related]

  • 30. Effect of treatment on growth in congenital adrenal hyperplasia.
    Ercan O, Hatemi S, Kutlu E, Turan N.
    Indian J Pediatr; 2000 Nov 01; 67(11):783-9. PubMed ID: 11216375
    [Abstract] [Full Text] [Related]

  • 31. Growth Trajectory and Adult Height in Children with Nonclassical Congenital Adrenal Hyperplasia.
    Wasniewska MG, Morabito LA, Baronio F, Einaudi S, Salerno M, Bizzarri C, Russo G, Chiarito M, Grandone A, Guazzarotti L, Spinuzza A, Corica D, Ortolano R, Balsamo A, Abrigo E, Baldini Ferroli B, Alibrandi A, Capalbo D, Aversa T, Faienza MF, Adrenal Diseases Working Group of the Italian Society for Pediatric Endocrinology and Diabetology.
    Horm Res Paediatr; 2020 Nov 01; 93(3):173-181. PubMed ID: 32810858
    [Abstract] [Full Text] [Related]

  • 32. [Growth and adult height in patients with congenital adrenal hyperplasia].
    Kolousková S, Zemková D, Snajderová M, Lebl J.
    Cas Lek Cesk; 1995 Nov 01; 134(21):689-91. PubMed ID: 8556761
    [Abstract] [Full Text] [Related]

  • 33. Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method.
    Bonfig W, Schwarz HP.
    J Pediatr Endocrinol Metab; 2012 Nov 01; 25(7-8):645-9. PubMed ID: 23155688
    [Abstract] [Full Text] [Related]

  • 34. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
    Quintos JB, Vogiatzi MG, Harbison MD, New MI.
    J Clin Endocrinol Metab; 2001 Apr 01; 86(4):1511-7. PubMed ID: 11297576
    [Abstract] [Full Text] [Related]

  • 35. Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Dörr HG.
    Horm Res; 2007 Apr 01; 68 Suppl 5():93-9. PubMed ID: 18174719
    [Abstract] [Full Text] [Related]

  • 36. Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH).
    Hoyer-Kuhn H, Eckert AJ, Binder G, Bonfig W, Dübbers A, Riedl S, Woelfle J, Dörr HG, Holl RW.
    J Clin Endocrinol Metab; 2023 Oct 18; 108(11):e1199-e1204. PubMed ID: 37256841
    [Abstract] [Full Text] [Related]

  • 37. Persistence of delayed adrenarche in boys with thalassemia.
    Filosa A, Di Maio S, Esposito G, De Martinis F, De Terlizzi F.
    J Pediatr Endocrinol Metab; 2001 Apr 18; 14(4):407-14. PubMed ID: 11327374
    [Abstract] [Full Text] [Related]

  • 38. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density.
    de Almeida Freire PO, de Lemos-Marini SH, Maciel-Guerra AT, Morcillo AM, Matias Baptista MT, de Mello MP, Guerra G.
    J Bone Miner Metab; 2003 Apr 18; 21(6):396-401. PubMed ID: 14586796
    [Abstract] [Full Text] [Related]

  • 39. Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis.
    Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB, Abu Elnour NO, Gallegos-Orozco JF, Fatourechi MM, Agrwal N, Lane MA, Albuquerque FN, Erwin PJ, Montori VM.
    J Clin Endocrinol Metab; 2010 Sep 18; 95(9):4161-72. PubMed ID: 20823467
    [Abstract] [Full Text] [Related]

  • 40. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.
    Stikkelbroeck NM, Van't Hof-Grootenboer BA, Hermus AR, Otten BJ, Van't Hof MA.
    J Clin Endocrinol Metab; 2003 Aug 18; 88(8):3525-30. PubMed ID: 12915631
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.